# A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

> **NCT06592989** · — · RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Pancreatic Neuroendocrine Neoplasm
- Sorafenib
- Gefitinib

## Interventions

- **DRUG:** sorafenib, gefitinib

## Key facts

- **NCT ID:** NCT06592989
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-09-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06592989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06592989, "A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06592989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*